Tech Center 1600 • Art Units: 1614 1629
This examiner grants 27% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18605928 | THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE | Non-Final OA | KOWA COMPANY, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy